KCM
PRAH

Kendall Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Kendall Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,555
Closed -$587K – 157
2021
Q2 		$587K Sell
3,555
-690
-16% -$115K 0.33% 86
2021
Q1 		$651K Sell
4,245
-2,777
-40% -$377K 0.4% 76
2020
Q4 		$881K Sell
7,022
-75
-1% -$8.39K 0.64% 52
2020
Q3 		$720K Sell
7,097
-1,900
-21% -$194K 0.63% 58
2020
Q2 		$875K Sell
8,997
-1,025
-10% -$95.4K 0.84% 45
2020
Q1 		$832K Sell
10,022
-225
-2% -$21.9K 0.94% 41
2019
Q4 		$1.14M Sell
10,247
-60
-0.6% -$6.17K 0.9% 43
2019
Q3 		$1.02M Sell
10,307
-275
-3% -$27.3K 0.9% 43
2019
Q2 		$1.05M Buy
10,582
+675
+7% +$64.4K 0.95% 40
2019
Q1 		$1.09M Buy
9,907
+142
+1% +$14.8K 1.04% 35
2018
Q4 		$898K Buy
9,765
+1,010
+12% +$102K 0.93% 38
2018
Q3 		$965K Buy
+8,755
New +$912K 0.82% 42

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Kendall Capital Management's PRAH Position: Q3 2021 in Review

Kendall Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,555 shares — an estimated $587K sold.

Kendall Capital Management first reported a position in PRAH in Q3 2018 and held it in 12 quarters. The position peaked at $1.14M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Kendall Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Kendall Capital Management sold 3,555 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $587K.
  • Kendall Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 12 quarters.
  • Kendall Capital Management's PRA Health Sciences, Inc. position peaked at $1.14M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Kendall Capital Management's 13F filing for Q3 2021, filed 5 Nov 2021.